Do You Need a License to Sell Peptides in California?

There is no standalone "peptide license" that a business applies for, so the honest answer is that it depends on what you are selling, how it is labeled, and who you are selling it to. Every business selling tangible goods generally carries an ordinary commercial paperwork layer — entity registration, a seller's permit or sales tax registration, local approvals — and none of that is peptide-specific. The peptide-specific layer is a separate question about whether the article you are moving is regulated as a drug or medical device, and whether distribution of that category requires licensure. Research-use-only material sold business-to-business sits in a different lane from anything intended for human use, and that distinction drives labeling, marketing language, customer screening, and sales channel.

This page is informational, not legal advice. Nobody at a supplier — including Real Peptides — can tell you which lane your specific business model falls into. That determination belongs to your attorney and, where relevant, the state agencies and boards that regulate your category of business.

Three separate questions hiding inside one

Most people asking this question are actually asking three at once, and the answers do not overlap.

The first is general commercial: can this entity legally operate and sell goods at all? That is registration, tax accounts, local permitting, and in some cases zoning if you are warehousing inventory yourself. It applies whether you sell research compounds, cosmetics, or office chairs. Your accountant and the state tax authority handle this layer, and it is the easiest of the three to resolve because the rules are published, generic, and stable.

The second is category-specific: does the material you intend to sell fall into a regulated class — drug, device, dietary supplement, cosmetic — and does moving that class of article require a distribution or wholesaler license? This is where general internet answers become worthless. The classification does not turn on the word "peptide." It turns on the article's intended use, its labeling, the claims made about it, and how it is presented to the buyer. Two businesses can ship physically similar vials and land in completely different regulatory positions because of what their labels and websites say.

The third is professional: if a licensed practice is involved, what does the relevant professional board expect of that practice? Medical, nursing, and pharmacy oversight is its own universe, entirely separate from whether a supplier can lawfully sell you something. A supplier answering that question for you would be overstepping.

Keeping these three separate is the single most useful thing you can do before you talk to counsel, because it turns one unanswerable question into three answerable ones.

What research-use-only actually constrains

Research-use-only is not a disclaimer you paste at the bottom of a page. It is a description of what the material is and how it may be represented, and it constrains the seller more than it constrains anything else.

In practical terms, it means the compound is supplied for laboratory research and is not for human consumption, not a therapeutic, and not an approved drug. That framing has to be consistent everywhere — product pages, invoices, packaging, email copy, ad creative, and the way your sales team talks. A business that stocks research compounds and then writes marketing copy describing outcomes for people has, in substance, changed the article's intended use regardless of what the fine print says. This is the most common way a compliant-looking catalog stops being one.

It also constrains who you sell to and how you verify them. Research-use-only supply is a business-to-business relationship with buyers who have a legitimate research or resale purpose. A supplier that ships to anyone with a credit card and no verification step is telling you something about how it thinks about the category.

Here is how the three lanes separate in practice:

Most of the confusion in this market comes from businesses that never separated row two from row three, then assumed a general business license covered both.

Questions to bring to your attorney, not to a supplier

Counsel works far better when you arrive with specific questions instead of "is this legal." A useful list looks something like this.

What is the regulatory classification of the specific articles I intend to stock, given my labeling and my marketing claims? Ask about the articles individually, not the category, because classification is article-by-article.

Does my business model involve distribution of any class of article that requires a wholesaler, distributor, or repackager license in the states I ship to or operate in? Ask separately about the state you are based in and any state you ship into, since requirements are not uniform and vary by category.

If a licensed practice is part of my structure, what do the applicable professional boards expect regarding sourcing, recordkeeping, and what may be represented to the public? Check with your state board directly; board guidance and attorney advice are not interchangeable.

What records should I retain for each lot I purchase and each lot I sell, and for how long? Chain-of-custody documentation is cheap to keep and expensive to reconstruct.

What language in my marketing would change the intended use of what I sell? Have counsel review actual copy, not a summary of it. This is where businesses most often create a problem they did not intend.

What is the correct answer when a customer asks a question my staff is not permitted to answer? Script it before it happens.

Rules differ by state, by category, and sometimes by county, and they change. Treat anything you read online — including this page — as a starting point for that conversation rather than a conclusion.

How to vet a wholesale supplier before you place an order

Whichever lane you end up in, your exposure runs through your supplier. If you cannot document what is in the vial, you cannot document anything downstream of it. Vet on evidence, not on the quality of someone's sales deck.

Ask whether the certificate of analysis is lot-matched. A generic COA for "BPC-157" is a marketing document. A COA tied to the specific lot number printed on the vial you received is a record. Ask which one you get, and ask to see an example before you order.

Ask whether COAs cost extra. Some sellers treat lab documentation as a paid add-on or release it only after purchase. Testing documentation is the product's evidence base; if it sits behind a paywall or a support ticket, ask yourself why. Publicly posted results you can check yourself, without asking permission, are a different standard entirely.

Ask what the testing panel actually covers. Identity and purity are the headline, but a serious panel goes further into contaminants and residuals. Ask which analyses are run per batch and what methods are used. "Third-party tested" with no panel description and no accessible report is an unverifiable claim.

Ask where pricing lives. Programs that hide all pricing behind a sales call are often optimizing for negotiation leverage rather than partnership. Published tier structures let you model your own economics before you commit time to an application.

Ask where fulfillment originates and what the stated lead time is. Domestic fulfillment shortens your cash conversion cycle and removes a category of customs risk. Ask for the stated window in writing rather than accepting "fast shipping."

Ask whether the supplier verifies its buyers. A wholesale program that screens applicants is protecting the integrity of its own channel, and by extension yours.

Margins in this market vary widely with volume, category, and how you position your catalog, so be skeptical of any supplier that leads with a profitability figure instead of documentation. Numbers presented without a source are the same species of claim as testing presented without a report.

What Real Peptides does differently

Real Peptides operates a Wholesale Partner Program built for business buyers — med spas, clinics, wellness centers, telehealth companies, and resellers building their own catalogs — and the program is designed around the documentation problem described above.

Every compound is produced to 99%+ HPLC purity and undergoes 7-panel batch testing. Certificates of analysis are publicly verifiable, meaning a prospective partner can check the lab results independently, before applying and before spending anything. That is deliberate: documentation you have to request is documentation you cannot use to evaluate a supplier you have not yet chosen.

Fulfillment is handled from the United States with a stated 5–7 day window, which lets partners plan reorder cycles against a known lead time rather than an open-ended international transit estimate. Pricing tiers are structured rather than improvised, so partners can model volume economics against their own catalog plans.

The catalog itself is broad enough to build a coherent product line around, spanning research categories from tissue signaling and recovery through metabolic and longevity research, including well-known compounds available through the popular peptides collection. All compounds are supplied for laboratory research use only and are not FDA-approved drugs, are not for human consumption, and are not sold or described as therapeutics. That framing is consistent across the catalog, and partners are expected to maintain it in their own materials.

The qualification path for a wholesale account

The Wholesale Partner Program uses a three-step application. You submit your business details, the account is reviewed and verified, and approved partners get access to tier pricing and ordering. The verification step exists because a research-use-only channel only holds together if both sides of it are legitimate businesses.

Before you apply, do the internal work: confirm your entity registration and tax accounts are current, get your attorney's read on classification and any distribution licensure question specific to your model and your shipping footprint, and have your marketing copy reviewed so it matches how the material is actually supplied. Decide what your recordkeeping will look like — which lot numbers you track, where COAs are stored, how long you retain them — before your first inbound shipment rather than after.

The suppliers worth partnering with are the ones that make the evidence easy to check. If you have run the legal question to ground with your own counsel and you are ready to evaluate sourcing on documentation rather than promises, review the published testing, pricing structure, and program terms, then submit an application and let the verification process do its job.

For more detail on the broader question of licensure across markets, see do you need a license to sell peptides. Program terms, testing standards, and tier structure are laid out in the wholesale peptides program, and qualified businesses can apply for a wholesale account directly.